Anzeige
Mehr »
Sonntag, 30.08.2026 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0M4YV | ISIN: CNE100000411 | Ticker-Symbol: XIN
Stuttgart
28.08.26 | 21:55
0,600 Euro
0,00 % 0,000
Branche
Pharma
Aktienmarkt
ASIEN
1-Jahres-Chart
SHANDONG XINHUA PHARMACEUTICAL CO LTD Chart 1 Jahr
5-Tage-Chart
SHANDONG XINHUA PHARMACEUTICAL CO LTD 5-Tage-Chart
RealtimeGeldBriefZeit
0,6250,63029.08.

Aktuelle News zur SHANDONG XINHUA PHARMACEUTICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrSHANDONG XINHUA (00719): OVERSEAS REGULATORY ANNOUNCEMENT-ANNOUNCEMENT ON DAPOXETINE HYDROCHLORIDE TABLETS HAVING OBTAINED DRUG REGISTRATION CERTIFICATE1
DiShandong Xinhua Pharmaceutical Co Ltd H1 Profit Falls1
DiSHANDONG XINHUA Interim Net Profit RMB149 million, Down 33.35% YoY1
SHANDONG XINHUA PHARMACEUTICAL Aktie jetzt für 0€ handeln
DiSHANDONG XINHUA (00719): 2026 INTERIM RESULTS ANNOUNCEMENT-
21.08.SHANDONG XINHUA Receives Drug Registration Certificate for Dapagliflozin Tablets1
21.08.SHANDONG XINHUA (00719): OVERSEAS REGULATORY ANNOUNCEMENT-ANNOUNCEMENT ON DAPAGLIFLOZIN TABLETS HAVING OBTAINED DRUG REGISTRATION CERTIFICATE1
11.08.SHANDONG XINHUA (00719): ANNOUNCEMENT NOTICE OF BOARD MEETING-
10.07.Dividendenbekanntmachungen (10.07.2026)11.641 Unternehmen  ISIN-Code  Dividende (Währung)  Dividende (EUR)  ADVANCE AUTO PARTS INC  US00751Y1064  0,25 USD  0,2187 EUR  ALPHA BANK SA ADR  US02071M5076  0,0187 USD  0,0163 EUR  AMERICAN EAGLE OUTFITTERS...
► Artikel lesen
26.06.SHANDONG XINHUA (00719): ARTICLES OF ASSOCIATION-
26.06.SHANDONG XINHUA (00719): (I)POLL RESULTS OF THE ANNUAL GENERAL MEETING; AND (II)PAYMENT OF 2025 FINAL DIVIDEND-
26.06.SHANDONG XINHUA (00719): FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2025-
22.06.SHANDONG XINHUA (00719): OVERSEAS REGULATORY ANNOUNCEMENT-ANNOUNCEMENT ON OBTAINING THE NOTICE OF APPROVAL FOR DRUG CLINICAL TRIALS-
01.06.SHANDONG XINHUA (00719): OVERSEAS REGULATORY ANNOUNCEMENT-ANNOUNCEMENT ON OBTAINING THE DRUG REGISTRATION CERTIFICATE FOR SEVELAMER CARBONATE FOR SUSPENSION1
26.05.SHANDONG XINHUA (00719): REPLY SLIP FOR 2025 ANNUAL GENERAL MEETING-
26.05.SHANDONG XINHUA (00719): PROXY FORM FOR 2025 ANNUAL GENERAL MEETING-
26.05.SHANDONG XINHUA (00719): NOTICE OF THE ANNUAL GENERAL MEETING-
26.05.SHANDONG XINHUA (00719): PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION AND NOTICE OF THE ANNUAL GENERAL MEETING-
18.05.SHANDONG XINHUA (00719): OVERSEAS REGULATORY ANNOUNCEMENT-ANNOUNCEMENT ON PHENOBARBITAL TABLETS HAVING PASSED THE GENERICS CONSISTENCY EVALUATION-
11.05.SHANDONG XINHUA (00719): OVERSEAS REGULATORY ANNOUNCEMENT-ANNOUNCEMENT ON AMBROXOL HYDROCHLORIDE AND CLENBUTEROL HYDROCHLORIDE ORAL SOLUTION HAVING OBTAINED ...2
08.05.SHANDONG XINHUA (00719): OVERSEAS REGULATORY ANNOUNCEMENT-ANNOUNCEMENT ON BENSERAZIDE HYDROCHLORIDE HAVING OBTAINED THE NOTIFICATION OF APPROVAL OF MARKETING ...2
Weiter >>
42 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1